Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.